Findings

What do systematic reviews say?

962 questions · 1,000 findings · 69 reviews · Urology

Sort:Best matchNewestHighest certainty Download CSV

No studies found 196 · 19.6%GRADE not reported 33 · 3.3%Very low 198 · 19.8%Low 354 · 35.4%Moderate 206 · 20.6%High 13 · 1.3%

PUL vs TURP

Ejaculatory function

2 findings from 1 review

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 56 participants
Low
Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 59 participants
Moderate

PUL vs sham

Urological symptom scores

1 finding from 1 review

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 206 participants
Low

PUL vs sham

Quality of life

1 finding from 1 review

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 206 participants
Moderate

PUL vs sham

Major adverse events

It is very uncertain whether PUL changes major adverse events compared with sham (very low certainty).

1 finding from 1 review

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
RR 3.3 [0.41, 26.28]
1 study · 206 participants
Very low

PUL vs sham

Retreatment

1 finding from 1 review

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 206 participants
Low

PUL vs sham

Erectile function

1 finding from 1 review

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 197 participants
Moderate

PUL vs sham

Ejaculatory function

1 finding from 1 review

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 144 participants
Moderate

PUL vs TURP

Quality of life

2 findings from 1 review

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 72 participants
Low
Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 69 participants
Low

PUL vs TURP

Major adverse events

It is very uncertain whether PUL changes major adverse events compared with TURP (very low certainty).

2 findings from 1 review

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
RR 0.64 [0.18, 2.19]
1 study · 79 participants
Very low
Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Aquablation vs transurethral resection of the prostate

Urologic symptom scores · men with benign prostatic hyperplasia

1 finding from 1 review

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 174 participants
Moderate

Aquablation vs transurethral resection of the prostate

Quality of life · men with benign prostatic hyperplasia

1 finding from 1 review

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 174 participants
Low

Aquablation vs transurethral resection of the prostate

Major adverse events · men with benign prostatic hyperplasia

It is very uncertain whether aquablation changes major adverse events compared with transurethral resection of the prostate (very low certainty).

1 finding from 1 review

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
RR 0.84 [0.31, 2.26]
1 study · 181 participants
Very low

Aquablation vs transurethral resection of the prostate

Retreatment · men with benign prostatic hyperplasia

It is very uncertain whether aquablation changes retreatment compared with transurethral resection of the prostate (very low certainty).

1 finding from 1 review

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
RR 1.68 [0.18, 15.83]
1 study · 181 participants
Very low

Aquablation vs transurethral resection of the prostate

Erectile function · men with benign prostatic hyperplasia

1 finding from 1 review

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 64 participants
Very low

Aquablation vs transurethral resection of the prostate

Ejaculatory function · men with benign prostatic hyperplasia

1 finding from 1 review

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 121 participants
Very low

Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy

Time to bladder cancer recurrence (absolute effect size estimates based on recurrence rate at 12 months)

Single‐dose intravesical chemotherapy instillation may leads to lower time to bladder cancer recurrence (absolute effect size estimates… compared with placebo or observation after nephroureterectomy (low certainty).

1 finding from 1 review

Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma 2019 · Cochrane Headline outcomes only
HR 0.51 [0.32, 0.82]
2 studies · 311 participants
Low

Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy

Time to death from UTUC5

The review found no eligible studies for this question.

1 finding from 1 review

Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy

Serious adverse events

1 finding from 1 review

Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 311 participants
Very low

Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy

Time to death from any cause5

The review found no eligible studies for this question.

1 finding from 1 review

Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy

Minor adverse events

1 finding from 1 review

Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 72 participants
Very low